Home Medicine “There is generally no focus on my pain from the healthcare staff”: A qualitative study exploring the perspective of patients with Parkinson’s disease
Article Open Access

“There is generally no focus on my pain from the healthcare staff”: A qualitative study exploring the perspective of patients with Parkinson’s disease

  • Andrea Søndergaard Armbruster EMAIL logo , Susan Tomczak Matthiesen , Christina Jensen-Dahm , Mette Møller , Nanna Brix Finnerup and Lene Vase
Published/Copyright: November 15, 2025
Become an author with De Gruyter Brill

Abstract

Objectives

Pain is a prevalent non-motor symptom in patients with Parkinson’s Disease (PD) and associated with significant quality-of-life impairments. Yet, qualitative literature examining how patients with PD experience their pain and pain treatment is scarce. The aim of this study is to understand and report firsthand experiences with pain in PD.

Methods

Individual interviews (N = 15 patients with PD) following a semi-structured interview guide organized in 7 main topics and 18 subtopics covering both medical and psychological aspects of pain in PD. Data were analyzed by a reflexive thematic analysis.

Results

Three major themes emerged: (1) Pain is related to PD: A majority of interviewees were confident pain is caused by motor symptoms and related to sleep disturbances. (2) Healthcare professionals neglect pain in PD: frequently, interviewees expressed satisfaction with general PD treatment, yet urged healthcare professionals to show interest in their pain. Many were uncertain as to who was responsible for pain treatment and wished for increased coordination among healthcare professionals. (3) Treatment of pain is insufficient: self-medication was prevalent. Most interviewees told they hide their pain. Interviewees broadly reported low and/or temporary effect of alternative pain treatment, yet perceived training as efficient. Multiple interviewees called for research on physical or psychological rather than pharmacological pain treatment.

Conclusion

Patients with PD yearn for dialogue on pain with healthcare professionals. Frequently, patients take medication unsupervised, suggesting a need for integrating assessment of self-medication in standard treatment regimes. Patients urge healthcare professionals to discuss pain with them and acknowledge that motor symptoms may cause pain.

1 Introduction

Pain is a common non-motor symptom in Parkinson’s disease (PD) [1] with reported prevalence ranging from 40% [2] to 95.5% [3]. PD is a neurodegenerative disorder, which in 2016 affected around six million people on a worldwide scale [4]. During the past two decades, the incidence has grown markedly [5], and PD is estimated to be the fastest growing neurodegenerative disorder throughout the world [6]. Pain in PD is associated with significant impairments such as low quality of life and increased depression and anxiety [3].

Studies on PD have predominantly investigated motor symptoms [7], and treatment of motor symptoms is complicated, yet largely standardized [8]. In contrast, research on pain in PD is scarce, and prior studies found pain treatment in PD to be limited, unsystematic, and often having temporary effect [3,9,10,11,12]. Thus, research on the nature and treatment of pain in PD is needed.

When detecting novel research terrains and investigating how to optimize treatment of neurodegenerative disorders, it is considered crucial to study patients’ core needs [13]. The dominant method to get insights in such needs is qualitative interviews [13,14,15,16]. Yet, qualitative interviews on the experience of pain and its management in people with PD are scarce [14]. Thus, in the present study, we conducted interviews with patients with PD to explore firsthand experiences with pain and describe which pain elements patients consider crucial for further investigation. The aim of the study was to explore patients’ perspectives on topics potentially associated with pain in PD such as disease history [17], general health [18], sleep [19,20], and quality of life [21,22]. Also, the study aimed to explore how patients experience communication with healthcare professionals and satisfaction with different pain treatments [23], and their wishes for future research [13].

2 Materials and methods

2.1 Qualitative method

We applied a reflexive thematic analysis to explore the complexity and rich nuances of pain in PD [24]. This qualitative method was chosen as it places great emphasis on the influence of the subjectivity of investigators in a study. The method allowed us to recognize and integrate the mutual relation between us as researchers and patients in the study. Thus, this method allowed us to gain in-depth insights into firsthand experiences with the topic, i.e., how patients perceive, interpret, and make sense of pain in PD.

2.2 Design

Fifteen semi-structured individual interviews [25] were conducted at the Department of Psychology and Behavioral Sciences at Aarhus University, Denmark (N = 13) or online via Zoom (N = 2).

2.3 Data collection

Data were collected between 25 January, 2022 and 15 February, 2022. All interviews followed the same interview guide and procedure and were conducted by the same interviewer.

2.3.1 Interview guide

A semi-structured interview guide [25] was developed by neurologists (CJD; MM; NBF) and specialists in neuroscience and psychology (STM; LV), all experts on PD and/or pain. The interview guide was organized in seven main topics covering both medical and psycho-neurobiological aspects of pain in PD. For each main topic, additional subsections were created (Table 1). Interview questions were mainly open-ended [26]. Interview guide was tested in an initial pilot, which gave no reason for adjustments.

Table 1

Interview topics

Main topic Subtopic Purpose and literature
1. Disease characteristics
  • Date of PD diagnosis

  • PD symptoms

  • Treatment and sequelae

Describe anamnesis [17]
2. Pain and health prior to PD
  • Health prior to PD

  • Pain levels, tolerance, and attributions

  • Extreme pain experiences

Explore how patients experience pain [18]
3. Pain and health post PD
  • The association between pain and PD

  • Causes of pain

  • Pain levels, tolerance, and attributions

  • Factors enhancing and decreasing pain

Explore how patients experience pain [18]
4. Pain treatment
  • Pain and PD treatment

  • Communication with health care professionals

Describe patients’ satisfaction with pain treatment [23]
5. Sleep
  • Sleep prior and post PD

  • Sleep attributions and rest

Explore how patients experience the relation between sleep and pain [19,20]
6. Quality of life
  • Pain and everyday life

  • Pain and quality of life before and after PD

  • General health (5Q-5D-5L)

Describe how patients experience pains effect on their quality of live [21,22]
7. Future research
  • Preferences and wishes for novel studies

Explore patients core needs regarding future research [13]

2.3.2 Procedure

Upon arrival, participants were greeted by interviewer (STM). The interviewer gave the participant a standardized introduction to the interview session, which included briefing on the purpose, structure, and approximate duration of the interview followed by information on confidentiality and legal rights related to participation. Interviews were conducted in Danish and followed the interview guide accomplished by prompt and follow-up questions. All interviews were audio recorded. Mean duration of interviews was 50 min. Interviews were closed by debriefing participants on publication of collected data. Immediately after interviews, participants completed questionnaires on demographics (Table 2). No interviews were repeated.

Table 2

Participant characteristics

Feature N %
Gender
Women 6 40
Men 9 60
Age (Years), mean value ± SD 67.3 ± 7.1
Months with PD, mean value ± SD 64.9 ± 49.3
Pain before PD diagnosis
No 11 73.3
Yes 4 26.6
Pain after PD diagnosis
No 1 6.6
Yes 14 93.3

2.3.3 Interviewer

Interviews were conducted by STM who has a PhD degree in psychology specialized in pain and worked as a postdoc at Aarhus University, Denmark. STM had formal training and experience in qualitative research and interview techniques. STM had no established connections to participants prior to the study. During interview sessions, STM would introduce herself and members of the research team on the project but gave no further details on their individual characteristics.

2.4 Sample

Participants were recruited from the Danish Parkinson´s foundation district Eastern Jutland, Denmark. Vice chair of the district approached all members of the foundation (N = 833) by email to introduce the study. Interested participants responded to investigator STM either by email or phone call (N = 25) and would then receive further verbal information on the study and assessment of eligibility. Inclusion criteria: diagnosed with PD by means of the MDS clinical diagnostic criteria for Parkinson´s disease [27]. Exclusion criteria: inability to speak and understand Danish.

After 15 interviews, the investigators experienced data redundancy where the same nuances were observed repeatedly across interviews and thus concluded saturation was reached [28,29]. To acquire adequate variation in range of patient experiences, the study used a purposeful sampling strategy [30] aiming for heterogeneity regarding gender, age, and PD severity. Subjects excluded due to control of heterogeneity (N = 10 men) were notified immediately when they contacted STM.

Participants were nine men and six women (Table 2). Participants received a box of chocolate as compensation for participation.

2.5 Data analysis

Recorded interviews were transcribed, reproducing speech content verbatim, without paraverbal communication. Transcripts were not returned to participants for comments. Then, ASA and STM conducted a reflexive thematic analysis [31] to identify, analyze, and interpret patterns of meaning on pain in PD across interviews. The analytic process had six stages and in accordance with standard procedures [32], investigators moved back and forth between stages.

First, ASA and STM independently familiarized themselves with data (stage 1) by reading and re-reading all transcribed interviews. When reading interviews, both investigators noted inductive initial ideas for categorization in the right-hand margin when finding interview data relevant for a rich and nuanced understanding of the topic. E.g., ASP noted “Experience pain as related to PD” next to the passage “Pain is caused by the rigidity you get - the stiffness.”

Next ASA and STM generated initial codes (stage 2). They made coding trees based on their inductive ideas for categorization. Then, they read each transcript systematically and repeatedly while searching for similarities and contradictions across interviews in relation to coding trees. Codes were words, phrases, or sentences that captured a meaningful pattern across interviews, e.g., “The nature of pain in PD.” For each code, ASA and STM gathered relevant interview data, i.e., written passages from all transcribed interviews, which were connected to the code. Completing this analytic stage, ASA and STM shared and discussed their individual initial coding.

ASA constructed themes (stage 3). Investigators located both latent and manifest patterns of meaning across interviews and organized codes into themes describing firsthand experiences with pain in PD, e.g., “Treatment of pain is insufficient.”

Themes were reviewed by ASA, STM and LV (stage 4) who controlled that each theme matched both codes and full dataset. A thematic map of analysis was generated in which a total of five candidate themes were reduced to three.

Then, clear definitions of each theme were created (stage 5) by ASA through an ongoing analysis. ASA identified major themes, e.g., “pain is related to PD” as well as diverse cases and minor themes, e.g., “PD motor symptoms cause pain.”

ASA produced the report (stage 6) and validated findings by referring each theme to words, sentences, and passages in transcribed interview. The report was continuously revised in consultation with STM and LV. ASA controlled consistency between conclusions vs literature, transcribed interviews and initial research question of how patients with PD experience their pain and pain treatment. Quotes illustrating each theme were selected and translated from Danish to English by a professional translator. Findings were reported in accordance with the Consolidated Criteria for Reporting Qualitative Research checklist [33].

3 Results

Three major themes on pain in PD emerged from the data analysis. Each major theme compresses minor themes specifying nuances and multilayers in data. Please refer “ Table 3 : Results.

Table 3

Results

Major theme Minor theme N % Examples of words used by patients
Pain is related to PD PD and pain cannot be separated 13 87 Pain and PD are intertwined; you cannot separate Parkinson’s diagnosis and pain; pain and PD must be understood holistically; it is difficult to separate the various elements; a cumulative relationship (the more PD symptoms, the more pain); it is PD that causes me pain
PD motor symptoms cause pain 7 47 Pain is caused by the rigidity you get – the stiffness; pain is caused by Parkinson´s (…) the muscles are kind of overloaded; Pain arises because the muscles are not used
Pain and sleep are related 11 73 Pain affects sleep; daily rest has a good effect on pain; sleep has a good effect on pain in the shoulder and neck and buttocks; good sleep relieves pain
Healthcare professionals neglect pain in PD Satisfied with treatment of PD but dissatisfied with treatment of pain 11 73 They have been fantastic (regarding treatment of PD); When I mentioned pain he did not want to talk about it and tried to separate it from PD; I feel much heard (regarding treatment of PD); there is no response when I say that I am in pain; I have not experienced that people have asked about my pain; not feeling heard; there is no consistency with regard to the treatment of pain; I don’t feel heard enough; I believe they do not know enough about it (pain in PD); there is generally no focus on pain from healthcare staff
It is unclear who is responsible for treatment of pain in PD 12 88 It falls between two chairs; it is “unclear” and “confusing” to find out who takes care of what in relation to pain; I am in a room where I don’t know what to do; I am exalted above doctor and neurologist; No one asks about pain
Treatment of pain is insufficient Self-medication is prevalent 10 67 Just take extra medicine; then I just take the wife’s medicine (unprescribed pain killers); medicine reduces pain; my pain went away when I started taking Parkinson’s medicine; I took three pain killers on average per day; I get two pain killers every night
Alternative pain treatment, e.g., acupuncture, has low and/or temporary effect 7 47 It works occasionally; it helped at first (…) but now I think the effect has somewhat diminished; it didn’t really help - nothing I could establish; It didn’t make much of a fuss; I don’t want alternative treatment; many years ago, I tried some acupuncture, but it didn’t help me
Training relieves pain 11 73 Exercise helps a lot; The way forward is training; I believed that training would be the cure for my illness or diagnosis

3.1 Theme 1: Pain is related to PD

3.1.1 PD and pain cannot be separated

Almost all interviewees experienced pain in their daily life. The majority of interviewees experiencing pain described pain and PD as being related. Interviewees often expressed no reservations regarding an association between PD and pain. They characterized the two conditions as “intertangled,” “not possible to disconnect,” “needs to be perceived in a holistic manner,” etc. Specifically, interviewees repeatedly emphasized that they considered pain as caused by PD and articulated that they were confident they would not experience pain if they did not suffer from PD. Regarding which specific PD features caused pain, interviewees expressed varying perceptions. Yet, two features were frequently highlighted across interviews: PD motor symptoms and sleep disturbances.

3.1.2 PD motor symptoms cause pain

Interviewees highlighting PD motor symptoms often specified that they believed that the development of pain was caused by symptoms such as dyskinesia or rigidity. An interviewee expressed the association as:

“I think it (pain) is related to Parkinson´s. Yes, I do. And I do so because pain is caused by the rigidity you get - the stiffness, you know.”

Interviewees who portrayed PD motor symptoms as the cause of pain described the association in a linear manner.

3.1.3 Pain and sleep are related

Interviewees who emphasized sleep disturbances often portrayed a reinforcing relation between pain in PD and sleep in a circular rather than linear manner. Interviewees experienced a positive reinforcement, e.g., undisturbed sleep at night would decrease pain the following day, which would decrease the likelihood of sleep disruption due to pain the next night. In addition, they also experienced negative reinforcement, e.g., pain disrupting sleep at night, which would decrease pain tolerance the following day.

Some of the interviewees who viewed pain and PD as related described consultations where healthcare professionals told them that pain and PD was not related. Discrepancies between patient perception and healthcare professionals’ perception were often described as a source of frustration. An interviewee narrated a consultation as

“This September when I last went to see the neurologist, I complained about the back pain, and then he said: ‘Parkinson’s does not cause pain. You don’t get pain because of Parkinson’s’ Period. That was his point of view.”

When asked about wishes for future research, interviewees recurrently requested studies examining the association between pain and PD thoroughly.

3.2 Theme 2: Healthcare professionals neglect pain in PD

3.2.1 Satisfied with treatment of PD but dissatisfied with treatment of pain

Interviewees frequently expressed varying satisfaction with healthcare system. Regarding focus on and care of PD generally, interviewees predominantly expressed high levels of satisfaction and characterized employees in the healthcare system as “engaged,” “skilled,” and someone they have “trust in.” However, regarding focus on and care of pain in PD, interviewees often expressed dissatisfaction and described how they do not feel heard when initiating a dialogue concerning their pain and broadly consider treatment of pain in PD neglected.

3.2.2 It is unclear who is responsible for treatment of pain in PD

To many interviewees, it was unclear who in the healthcare system was responsible for treatment of their pain. Often interviewees narrated how both neurologist and practitioner neglected pain symptoms. Thus, they expressed how no one took care of their pain symptoms and felt left alone regarding this matter. Multiple interviewees described feelings of uncertainty in a physical manner, e.g., “being in a room without knowing who to talk to,” “it (pain) falls in between two chairs.” An interviewee described the uncertainty as

“After all you find yourself between the doctor and the neurologist. You see, the neurologist says: ‘It’s not Parkinson´s - you need to talk to a general practitioner.’ The doctor says: ‘You need to ask the neurologist.’ And there I am – caught in the middle.”

However, a few interviewees described how they preferred to hide their pain from both professionals (e.g., practitioner and neurologist) and private surroundings (e.g., spouses or friends). These interviewees concealed pain due to fear of stigmatization and described how they were, e.g., “afraid of showing it to others” or “it would not be good if I pity myself, - become a victim.”

Regarding wishes to the healthcare system, interviewees often requested optimization of interdisciplinary collaboration and increased coordination concerning treatment of different PD features including pain.

3.3 Theme 3: Treatment of pain is insufficient

3.3.1 Self-medication is prevalent

Frequently, interviewees treated their pain by use of drugs unsupervised by their neurologist or general practitioner. Self-medication included increasing the dose of PD medication without consent or administration of over-the-counter pain killers. Some of these interviewees medicated themselves on a daily basis.

3.3.2 Alternative pain treatment has low and/or temporary effect

All interviewees who currently or in the past received alternative pain treatment, predominantly acupuncture, reported low or temporary effect.

3.3.3 Training relieves pain

Training was often highlighted as a most effective pain treatment. One interviewee applied training as pain management method to a degree she described as “an obsession.” Also, few expressed beliefs in training as a cure for both pain and PD in general.

When expressing wishes to future research, interviewees frequently requested studies on physical and psychological treatments of pain in PD rather than pharmacological treatments. In this regard, some interviewees explained how patients with PD often receive much medication and thus do not wish to increase intake of drugs. An interviewee described it as

“I think I take enough pills in general. Thus, I find it relevant for research to study other ways to reduce pain such as how thoughts and beliefs about pain can actually affect pain levels”

Specifically, interviewees often requested studies comparing the effect of different types of training or research on psychological coping strategies on pain management.

4 Discussion

Three major themes emerged from the data. First, interviewees perceived pain as related to PD, i.e., caused by motor symptoms and related to sleep disturbances. Second, interviewees described how healthcare professionals neglect pain in PD. Many were in this regard uncertain as to who was responsible for pain treatment and wished for more coordination among healthcare professionals. Third, according to interviewees, treatment of pain is insufficient, which leads to self-medication and hiding or suppressing pain. Interviewees often reported low and/or temporary effect of alternative pain treatment, yet they perceived training as efficient. These three major themes entail several points for discussion.

4.1 Patients believe that PD and pain are related but describe that healthcare professionals disagree – we encourage healthcare professionals to be aware that patients experience a discrepancy

Most participants in the current study expressed that they experience pain on a daily basis, which confirms existing literature reporting high prevalence of pain in PD [1,3,14,34]. Likewise, participants were confident that their pain was related to PD and they believed that pain in PD is caused by motor symptoms, in accordance with previous studies [14], and associated with sleep disturbances. Nuancing, participants often described how they experience healthcare professions believe that pain is not related to PD (Figure 1). Literature suggests patients have diverse perceptions regarding the causes of pain in PD [14]. Yet causative beliefs can be shaped by options of health care professionals. This could indicate a need for investigating the specific association between PD and pain further. It is recognized that pain may or may not be related to PD depending on the type of pain [35,36]. While adequate classification may be important for the treatment of pain in PD, identifying the underlying cause in an individual patient can be difficult [37]. Our results indicate that it is important to discuss pain and patient beliefs as a course of pain.

Figure 1 
                  The discrepancy in beliefs on pain in PD. Adapted from Unsplash (Stock Photo ID: 1248780171, uploaded June 24, 2020). Available at: https://unsplash.com.
Figure 1

The discrepancy in beliefs on pain in PD. Adapted from Unsplash (Stock Photo ID: 1248780171, uploaded June 24, 2020). Available at: https://unsplash.com.

4.2 Investigate the relation between sleep and pain in PD further

Despite a growing number of scholars exploring the complex relation between PD and pain in PD, our knowledge of the issue is yet incomplete and we encourage further studies testing the specifics of the relation. Specifically, participants in our study emphasized that they experience a reinforcing association between sleep and pain in PD in accordance with findings from studies on sleep disturbances and other PD symptoms [38]. Also, multiple studies document that pain is a significant factor in contributing to sleep interference in other pain conditions, e.g., chronic neuropathic pain in spinal cord injury [39,40], which in combination with our study findings emphasizes the need for addressing sleep problems.

4.3 Optimize the dialogue between patients and healthcare professions regarding pain in PD

Many participants in our study described that health care professionals neglect their pain, and they yearned for more focus on pain in PD. Similar findings have been documented in studies of pain in PD [14] and other pain conditions, e.g., spinal cord injury neuropathic pain [40]. Our study suggests that patients and healthcare professionals may have different perceptions of PD symptoms and different expectations to pain treatment. This result supplements previous studies’ finding of PD patients’ perspectives on the most troublesome symptoms to frequently differ from clinicians’ perspectives [41]. Clinicians predominantly characterize PD by its motor symptoms and perceive non-motor symptoms as untreatable [22]; however, patients may perceive non-motor symptoms as having a greater impact as PD advances, and even in early PD stages, patients rank pain in the top 5 most troublesome symptoms [41]. Such discrepancy in perspectives between patient and practitioner has been proven to hamper treatment effectiveness [41]. Thus, a significant message from our study is to optimize the dialogue between patients and healthcare professions regarding pain in PD. Successful communication is significant for creating patient satisfaction, yet it is complicated in practice and often an issue in the healthcare system [42]. When optimizing the dialogue, we recommend healthcare professionals to consider our finding that some patients hide their pain due to fear of stigmatization, which is in accordance with previous studies [43,44]. Initiating a dialogue with these patients is highly important since self-stigmatization in PD is a determinant of quality of life [45] and can be a burden for caregivers [46].

4.4 Enhance patient centeredness in the treatment of pain in PD

Participants in our study frequently expressed satisfaction with PD treatment, yet they were dissatisfied with pain treatment. They were unsure of who is responsible for treatment of their pain; this is in accordance with previous literature [47]. In our study, patients wished for clarity regarding roles and responsibilities among professionals in pain treatment. Clarity can be optimized by implementing patient-centered treatment strategies in which healthcare professionals actively investigate and understand each patients’ needs and values [48]. Strategies include assessment of patient expectations to treatment outcome and aligning these with expectations of healthcare professionals. Implementing such strategies would be in accordance with literature suggesting patients with PD yearn for more patient centeredness in treatment [49], and with experts recommending healthcare systems to optimize patient centeredness in treatment of PD [49,50]. However, as healthcare systems worldwide are currently challenged by increasing complexity and decreasing resources [51], implementing these strategies in clinical practice can be timely and costly.

4.5 Assess self-medication

From this study, treatment of pain in PD appears insufficient. A high number of participants treated their pain via medication unsupervised by a healthcare professional. Self-medication included increasing doses of ordinated PD medication and taking over-the-counter pain killers. Similar results have been documented in studies of other pain conditions [39]. Self-medication is associated with major risks, e.g., delays in appropriate treatment and incorrect dosage [52]. In addition, unsupervised self-medication challenges monitoring adverse events. Also, the frequent use of pain killers among participants in our study relates to literature reporting pain killers to be the most frequently used pain treatment [3,9]. To optimize pain treatment in PD, we recommend healthcare systems to incorporate assessment of self-medication in standard treatment regimes.

4.6 Compare the effect of different kinds of non-pharmacological and non-invasive treatments

An important message from participants is their request for future studies comparing the effect of different kinds of non-pharmacological and non-invasive treatment of pain. Broadly, patients experienced low and/or temporary effect of alternative pain treatment, confirming existing literature on the topic [3]. Participants in our study experienced training as a most efficient pain treatment, which is in accordance with previous studies reporting physical activity as most effective, i.e., physiotherapy and rehabilitative therapy decrease musculoskeletal pain [3,9] and exercise can reduce pain [14]. We encourage future studies of exercise training to specify effects on different pain subtypes based on previous studies showing that PD treatments may have different effects in different types of PD-related pain.

4.7 Clinical relevance and future perspectives

This study opens new avenues for multiple steps to optimize assessment and treatment of pain in PD in clinical practice. First, as patients describe pain as related to PD while experienced health care professionals disagree, the specific relation should be investigated in each individual patient case. Second, patients in the study were satisfied with PD treatment, yet dissatisfied with treatment of pain in PD and yearning for dialogue with healthcare professionals in this regard. Thus, healthcare professionals can initiate a dialogue with patients on why satisfaction with general PD treatment is high and how to transfer this to treatment of pain in PD. Furthermore, in the dialogue, healthcare professionals can discuss self-management and other non-pharmacological treatment methods. Finally, participants in our study frequently treated their pain by use of medicine without supervision of healthcare professionals, and in this regard, we recommend integrating assessment of unsupervised self-medication into standard treatment regimes.

We encourage future studies exploring the topic from the perspective of healthcare professionals. Also, participants in our study expressed a need for studies comparing the effect of different non-pharmacological and non-invasive treatments. Future large-scale controlled studies are encouraged to compare the effect of different physical activities, and control for effects on different pain types.

5 Strengths and limitations

The sample was recruited from same district in the Danish Parkinson´s foundation, which may limit external validity of findings. However, the study optimized internal validity in various ways, e.g., data analysis was conducted by two researchers independently and recurringly discussed among all researchers. The study minimized bias by applying a purposeful sampling strategy aiming for heterogeneity of participants regarding gender, age, and PD severity. The sample heterogeneity could have been optimized further by including diversity in specific pain types [35].

In conclusion, this study collected firsthand experiences of pain in PD from the perspective of patients, whose main messages concerned their dialogue with healthcare professionals. They yearned for health care professionals to discuss pain with them and acknowledge that PD motor symptoms may cause pain. Patients described treatment of pain in PD as insufficient and articulated a need for optimizing pain treatment in clinical practice. Patients frequently treated their pain by use of unsupervised drugs suggesting assessment of self-medication must be integrated in standard treatment regimes.


tel: +4561110138

Acknowledgments

We thank all patients who participated in the interviews. Also, we thank Julie Kofoed Thomadsen and Mads Persson for transcription of eight interviews.

  1. Research ethics: The study was notified to the Central Denmark Region Committees on Health Research Ethics. According to the Consolidation Act on Research Ethics Review of Health Research Projects, Consolidation Act number 1338 of 1 September, 2020, section 14 (2), notification of interview surveys to the research ethics committee system is only required if the project involves human biological material and the committee concluded no approval was required. The study was accomplished in accordance with the Helsinki Declaration of 1975.

  2. Informed consent: Informed consent has been obtained from all individuals included in this study.

  3. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  4. Competing interests: Nanna B. Finnerup serves as Section Editor for Neuropathic Pain at Scandinavian Journal of Pain. Lene Vase is an Editor of Scandinavian Journal of Pain (Psychology of Pain and Pain Management). Rest of authors have no conflict of interest.

  5. Research funding: The study was funded by the Danish Parkinson’s foundation (Grant reference number: A1327). The funding party did not participate in designing the study, collecting and analyzing data, or writing the manuscript.

  6. Artificial intelligence/machine learning tools: Not applicable.

  7. Data availability: Dataset and interview guide are available from the corresponding author upon relevant request.

References

[1] Mylius V, Möller JC, Bohlhalter S, Ciampi de Andrade D, Perez Lloret S. Diagnosis and management of pain in Parkinson’s disease: A new approach. Drugs Aging. 2021;38(7):559–77. 10.1007/s40266-021-00868-7.Search in Google Scholar

[2] Broen MPG, Braaksma MM, Patijn J, Weber WEJ. Prevalence of pain in Parkinson’s disease: A systematic review using the modified QUADAS tool. Mov Disord. 2012;27:348–56. 10.1002/mds.24956.Search in Google Scholar PubMed PubMed Central

[3] Buhmann C, Wrobel N, Grashorn W, Fruendt O, Wesemann K, Diedrich S, et al. Pain in Parkinson disease: A cross-sectional survey of its prevalence, specifics, and therapy. J Neurol. 2017;264(4):758–69. 10.1007/s00415-017-8454-7.Search in Google Scholar PubMed PubMed Central

[4] Global, regional, and national burden of neurological disorders, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(5):459–80. 10.1016/S1474-4422(19)30024-3.Search in Google Scholar

[5] Bloem BR, Okun MS, Klein C. Parkinson’s disease. Lancet. 2021;397(10291):2284–303. 10.1016/S0140-6736(21)00381-6.Search in Google Scholar

[6] Deuschl G, Beghi E, Fazekas F, Varga T, Christoforidi KA, Sipido E, et al. The burden of neurological diseases in Europe: An analysis for the Global Burden of Disease Study 2017. Lancet Public Health. 2020;5(10):e551–e67. 10.1016/S2468-2667(20)30112-5.Search in Google Scholar

[7] Moustafa AA, Chakravarthy S, Phillips JR, Gupta A, Keri S, Polner B, et al. Motor symptoms in Parkinson’s disease: A unified framework. Neurosci Biobehav Rev. 2016;68:727–40. 10.1016/j.neubiorev.2016.07.017.Search in Google Scholar PubMed

[8] Rizek P, Kumar N, Jog MS. An update on the diagnosis and treatment of Parkinson disease. CMAJ. 2016;188(16):1157–65. 10.1503/cmaj.151179.Search in Google Scholar PubMed PubMed Central

[9] Buhmann C, Kassubek J, Jost WH. Management of pain in Parkinson’s disease. J Parkinsons Dis. 2020;10(s1):S37–48. 10.3233/JPD-202001244.Search in Google Scholar

[10] Liao X, Wu N, Liu D, Shuai B, Li S, Li K. Levodopa/carbidopa/entacapone for the treatment of early Parkinson’s disease: A meta-analysis. Neurol Sci. 2020;41(8):2045–54. 10.1007/s10072-020-04521-w.Search in Google Scholar

[11] Gandhi KR, Saadabadi A. Levodopa (L-Dopa). StatPearls. Treasure Island (FL): StatPearls Publishing; 2022. https://www.ncbi.nlm.nih.gov/books/NBK558872/.Search in Google Scholar

[12] Rana AQ, Qureshi D, Sabeh W, Mosabbir AA, Rahman E, Sarfraz Z, et al. Pharmacological therapies for pain in Parkinson’s disease – A review paper. Expert Rev Neurother. 2017;17:1209–19. 10.1080/14737175.2017.1364432.Search in Google Scholar

[13] Vlaanderen FP, Rompen L, Munneke M, Stoffer M, Bloem BR, Faber MJ. The voice of the Parkinson customer. J Parkinsons Dis. 2019;9(1):197–201. 10.3233/JPD-181512.Search in Google Scholar PubMed

[14] Nguy V, Brady B, Hassett LM, Canning CG, Elliott JM, Allen NE. A mixed methods approach to explore the experience of pain and its management in people with Parkinson’s disease. Parkinsons Dis. 2024;2024:8515400. 10.1155/2024/8515400.Search in Google Scholar PubMed PubMed Central

[15] Naisby J, Avery L, Baker K, Parkinson M, Hand A, Rochester L, et al. Living with pain and Parkinson’s: Developing an understanding of the impact, trajectory, and pain management needs: A qualitative interview study protocol. BMJ Open. 2024;14(12):e078754. 10.1136/bmjopen-2023-078754.Search in Google Scholar PubMed PubMed Central

[16] Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77–101. 10.1191/1478088706qp063oa.Search in Google Scholar

[17] Jankovic J. Parkinson’s disease: Clinical features and diagnosis. J Neurol Neurosurg Psychiatry. 2008;79:368–76.10.1136/jnnp.2007.131045Search in Google Scholar PubMed

[18] Balestrino R, Schapira AHV. Parkinson disease. Eur J Neurol. 2020;27(1):27–42.10.1111/ene.14108Search in Google Scholar PubMed

[19] Martinez-Martin P, Rizos AM, Wetmore JB, Antonini A, Odin P, Pal S, et al. Relationship of nocturnal sleep dysfunction and pain subtypes in Parkinson’s disease. Mov Disord Clin Pract. 2019;6(1):57–64.10.1002/mdc3.12694Search in Google Scholar PubMed PubMed Central

[20] van Gilst MM, Bloem BR, Overeem S. “Sleep benefit” in Parkinson’s disease: A systematic review. Parkinsonism Relat Disord. 2013;19(7):654–9.10.1016/j.parkreldis.2013.03.014Search in Google Scholar PubMed

[21] Quittenbaum BH, Grahn B. Quality of life and pain in Parkinson’s disease: A controlled cross-sectional study. Parkinsonism Relat Disord. 2004;10(3):129–36.10.1016/j.parkreldis.2003.12.001Search in Google Scholar PubMed

[22] Chaudhuri KR, Schapira AH. Non-motor symptoms of Parkinson’s disease: Dopaminergic pathophysiology and treatment. Lancet Neurol. 2009;8(5):464–74.10.1016/S1474-4422(09)70068-7Search in Google Scholar PubMed

[23] Speelman AD, van de Warrenburg BP, van Nimwegen M, Petzinger GM, Munneke M, Bloem BR. How might physical activity benefit patients with Parkinson disease? Nat Rev Neurol. 2011;7(9):528–34.10.1038/nrneurol.2011.107Search in Google Scholar PubMed

[24] Braun V, Clarke V. Reflecting on reflexive thematic analysis. Qual Res Sport Exerc Health. 2019;11(4):589–97.10.1080/2159676X.2019.1628806Search in Google Scholar

[25] Brinkmann S, Kvale S. InterViews: Learning the craft of qualitative research interviewing. Thousand Oaks, CA: SAGE Publications; 2014.Search in Google Scholar

[26] Weller SC, Vickers B, Bernard HR, Blackburn AM, Borgatti S, Gravlee CC, et al. Open-ended interview questions and saturation. PLoS One. 2018;13(6):e0198606.10.1371/journal.pone.0198606Search in Google Scholar PubMed PubMed Central

[27] Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, et al. MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord. 2015;30(12):1591–601.10.1002/mds.26424Search in Google Scholar PubMed

[28] Guest G, Bunce A, Johnson L. How many interviews are enough?: An experiment with data saturation and variability. Field Methods. 2006;18(1):59–82.10.1177/1525822X05279903Search in Google Scholar

[29] Sandelowski M. Sample size in qualitative research. Res Nurs Health. 1995;18(2):179–83.10.1002/nur.4770180211Search in Google Scholar PubMed

[30] Patton MQ. Qualitative research & evaluation methods. Thousand Oaks, CA: SAGE Publications; 2002.Search in Google Scholar

[31] Braun V, Clarke V. Thematic analysis: A practical guide. Los Angeles, USA: SAGE Publications, Limited; 2021.Search in Google Scholar

[32] Howitt D. Introduction to qualitative research methods in psychology. Harlow, United Kingdom: Pearson Education; 2019.Search in Google Scholar

[33] Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349–57.10.1093/intqhc/mzm042Search in Google Scholar PubMed

[34] Rukavina K, Cummins TM, Chaudhuri KR, Bannister K. Pain in Parkinson’s disease: mechanism-based treatment strategies. Curr Opin Support Palliat Care. 2021;15(2):108–15.10.1097/SPC.0000000000000546Search in Google Scholar PubMed

[35] Mylius V, Perez Lloret S, Cury RG, Teixeira MJ, Barbosa VR, Barbosa ER, et al. The Parkinson disease pain classification system: results from an international mechanism-based classification approach. Pain. 2021;162(4):1201–10.10.1097/j.pain.0000000000002107Search in Google Scholar PubMed PubMed Central

[36] Marques A, Attal N, Bouhassira D, Moisset X, Cantagrel N, Rascol O, et al. How to diagnose Parkinsonian central pain? Parkinsonism Relat Disord. 2019;64:50–3.10.1016/j.parkreldis.2019.04.025Search in Google Scholar PubMed

[37] Freynhagen R, Parada HA, Calderon-Ospina CA, Chen J, Rakhmawati Emril D, Fernández-Villacorta FJ, et al. Current understanding of the mixed pain concept: a brief narrative review. Curr Med Res Opin. 2019;35(6):1011–8.10.1080/03007995.2018.1552042Search in Google Scholar PubMed

[38] Moldofsky H. Sleep and pain. Sleep Med Rev. 2001;5(5):385–96.10.1053/smrv.2001.0179Search in Google Scholar PubMed

[39] Henwood P, Ellis JA. Chronic neuropathic pain in spinal cord injury: The patient’s perspective. Pain Res Manag. 2004;9(1):39–45.10.1155/2004/863062Search in Google Scholar PubMed

[40] Löfgren M, Norrbrink C. “But I know what works”–patients’ experience of spinal cord injury neuropathic pain management. Disabil Rehabil. 2012;34(25):2139–47.10.3109/09638288.2012.676146Search in Google Scholar PubMed

[41] Politis M, Wu K, Molloy S, G. Bain P, Chaudhuri KR, Piccini P. Parkinson’s disease symptoms: The patient’s perspective. Mov Disord. 2010;25(11):1646–51.10.1002/mds.23135Search in Google Scholar PubMed

[42] Coulter A, Fitzpatrick R. The patient’s perspective regarding appropriate health care. In The handbook of social studies in health and medicine. Thousand Oaks, CA: Sage Publications Ltd; 2000. p. 454–64.10.4135/9781848608412.n29Search in Google Scholar

[43] Hermanns M. The invisible and visible stigmatization of Parkinson’s disease. J Am Assoc Nurse Pract. 2013;25(10):563–6.10.1111/1745-7599.12008Search in Google Scholar PubMed

[44] Lin J, Ou R, Wei Q, Cao B, Li C, Hou Y, et al. Self-stigma in Parkinson’s disease: A 3-year prospective cohort study. Front Aging Neurosci. 2022;14:790897.10.3389/fnagi.2022.790897Search in Google Scholar PubMed PubMed Central

[45] Ma HI, Saint-Hilaire M, Thomas CA, Tickle-Degnen L. Stigma as a key determinant of health-related quality of life in Parkinson’s disease. Qual Life Res. 2016;25(12):3037–45.10.1007/s11136-016-1329-zSearch in Google Scholar PubMed PubMed Central

[46] Tan MMJ, Lim EC, Nadkarni NV, Lye WK, Tan EK, Kumar MP. The characteristics of patients associated with high caregiver burden in Parkinson’s disease in Singapore. Front Public Health. 2019;7:162.10.3389/fneur.2019.00561Search in Google Scholar PubMed PubMed Central

[47] Scascighini L, Toma V, Dober-Spielmann S, Sprott H. Multidisciplinary treatment for chronic pain: A systematic review of interventions and outcomes. Rheumatology (Oxford). 2008;47(5):670–8.10.1093/rheumatology/ken021Search in Google Scholar PubMed

[48] Edgman-Levitan S, Schoenbaum SC. Patient-centered care: Achieving higher quality by designing care through the patient’s eyes. Isr J Health Policy Res. 2021;10(1):21.10.1186/s13584-021-00459-9Search in Google Scholar PubMed PubMed Central

[49] van der Eijk M, Faber MJ, Al Shamma S, Munneke M, Bloem BR. Moving towards patient-centered healthcare for patients with Parkinson’s disease. Parkinsonism Relat Disord. 2011;17(5):360–4.10.1016/j.parkreldis.2011.02.012Search in Google Scholar PubMed

[50] van der Eijk M, Nijhuis FA, Faber MJ, Bloem BR. Moving from physician-centered care towards patient-centered care for Parkinson’s disease patients. Parkinsonism Relat Disord. 2013;19(11):923–7.10.1016/j.parkreldis.2013.04.022Search in Google Scholar PubMed

[51] Figueroa CA, Harrison R, Chauhan A, Meyer L. Priorities and challenges for health leadership and workforce management globally: A rapid review. BMC Health Serv Res. 2019;19(1):239.10.1186/s12913-019-4080-7Search in Google Scholar PubMed PubMed Central

[52] Ruiz ME. Risks of self-medication practices. Curr Drug Saf. 2010;5(4):315–23.10.2174/157488610792245966Search in Google Scholar PubMed

[53] Merton R. Insiders and outsiders: A chapter in the sociology of knowledge. Am J Sociol. 1972;78:9–47.10.1086/225294Search in Google Scholar

Received: 2024-10-07
Revised: 2025-09-08
Accepted: 2025-09-10
Published Online: 2025-11-15

© 2025 the author(s), published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Editorial Comment
  2. Abstracts presented at SASP 2025, Reykjavik, Iceland. From the Test Tube to the Clinic – Applying the Science
  3. Quantitative sensory testing – Quo Vadis?
  4. Stellate ganglion block for mental disorders – too good to be true?
  5. When pain meets hope: Case report of a suspended assisted suicide trajectory in phantom limb pain and its broader biopsychosocial implications
  6. Transcutaneous electrical nerve stimulation – an important tool in person-centered multimodal analgesia
  7. Clinical Pain Researches
  8. Exploring the complexities of chronic pain: The ICEPAIN study on prevalence, lifestyle factors, and quality of life in a general population
  9. The effect of peer group management intervention on chronic pain intensity, number of areas of pain, and pain self-efficacy
  10. Effects of symbolic function on pain experience and vocational outcome in patients with chronic neck pain referred to the evaluation of surgical intervention: 6-year follow-up
  11. Experiences of cross-sectoral collaboration between social security service and healthcare service for patients with chronic pain – a qualitative study
  12. Completion of the PainData questionnaire – A qualitative study of patients’ experiences
  13. Pain trajectories and exercise-induced pain during 16 weeks of high-load or low-load shoulder exercise in patients with hypermobile shoulders: A secondary analysis of a randomized controlled trial
  14. Pain intensity in anatomical regions in relation to psychological factors in hypermobile Ehlers–Danlos syndrome
  15. Opioid use at admittance increases need for intrahospital specialized pain service: Evidence from a registry-based study in four Norwegian university hospitals
  16. Topically applied novel TRPV1 receptor antagonist, ACD440 Gel, reduces temperature-evoked pain in patients with peripheral neuropathic pain with sensory hypersensitivity, a randomized, double-blind, placebo-controlled, crossover study
  17. Pain and health-related quality of life among women of childbearing age in Iceland: ICEPAIN, a nationwide survey
  18. A feasibility study of a co-developed, multidisciplinary, tailored intervention for chronic pain management in municipal healthcare services
  19. Healthcare utilization and resource distribution before and after interdisciplinary pain rehabilitation in primary care
  20. Measurement properties of the Swedish Brief Pain Coping Inventory-2 in patients seeking primary care physiotherapy for musculoskeletal pain
  21. Understanding the experiences of Canadian military veterans participating in aquatic exercise for musculoskeletal pain
  22. “There is generally no focus on my pain from the healthcare staff”: A qualitative study exploring the perspective of patients with Parkinson’s disease
  23. Observational Studies
  24. Association between clinical laboratory indicators and WOMAC scores in Qatar Biobank participants: The impact of testosterone and fibrinogen on pain, stiffness, and functional limitation
  25. Well-being in pain questionnaire: A novel, reliable, and valid tool for assessment of the personal well-being in individuals with chronic low back pain
  26. Properties of pain catastrophizing scale amongst patients with carpal tunnel syndrome – Item response theory analysis
  27. Adding information on multisite and widespread pain to the STarT back screening tool when identifying low back pain patients at risk of worse prognosis
  28. The neuromodulation registry survey: A web-based survey to identify and describe characteristics of European medical patient registries for neuromodulation therapies in chronic pain treatment
  29. A biopsychosocial content analysis of Dutch rehabilitation and anaesthesiology websites for patients with non-specific neck, back, and chronic pain
  30. Topical Reviews
  31. An action plan: The Swedish healthcare pathway for adults with chronic pain
  32. Team-based rehabilitation in primary care for patients with musculoskeletal disorders: Experiences, effect, and process evaluation. A PhD synopsis
  33. Persistent severe pain following groin hernia repair: Somatosensory profiles, pain trajectories, and clinical outcomes – Synopsis of a PhD thesis
  34. Systematic Reviews
  35. Effectiveness of non-invasive vagus nerve stimulation vs heart rate variability biofeedback interventions for chronic pain conditions: A systematic review
  36. A scoping review of the effectiveness of underwater treadmill exercise in clinical trials of chronic pain
  37. Neural networks involved in painful diabetic neuropathy: A systematic review
  38. Original Experimental
  39. Knowledge, attitudes, and practices of transcutaneous electrical nerve stimulation in perioperative care: A Swedish web-based survey
  40. Impact of respiration on abdominal pain thresholds in healthy subjects – A pilot study
  41. Measuring pain intensity in categories through a novel electronic device during experimental cold-induced pain
  42. Robustness of the cold pressor test: Study across geographic locations on pain perception and tolerance
  43. Experimental partial-night sleep restriction increases pain sensitivity, but does not alter inflammatory plasma biomarkers
  44. Is it personality or genes? – A secondary analysis on a randomized controlled trial investigating responsiveness to placebo analgesia
  45. Investigation of endocannabinoids in plasma and their correlation with physical fitness and resting state functional connectivity of the periaqueductal grey in women with fibromyalgia: An exploratory secondary study
  46. Educational Case Reports
  47. Stellate ganglion block in disparate treatment-resistant mental health disorders: A case series
  48. Regaining the intention to live after relief of intractable phantom limb pain: A case study
  49. Trigeminal neuralgia caused by dolichoectatic vertebral artery: Reports of two cases
  50. Short Communications
  51. Neuroinflammation in chronic pain: Myth or reality?
  52. The use of registry data to assess clinical hunches: An example from the Swedish quality registry for pain rehabilitation
  53. Letter to the Editor
  54. Letter to the Editor For: “Stellate ganglion block in disparate treatment-resistant mental health disorders: A case series”
  55. Corrigendum
  56. Corrigendum to “Patient characteristics in relation to opioid exposure in a chronic non-cancer pain population”
Downloaded on 10.1.2026 from https://www.degruyterbrill.com/document/doi/10.1515/sjpain-2024-0068/html
Scroll to top button